[ Price : $8.95]
Wired reports that several FDA-regulated companies have informed the Securities and Exchange Commission that their business could ...[ Price : $8.95]
Elon Musks Department of Government Efficiency (DOGE) terminates the leases of 30 FDA field offices and laboratories throughout th...[ Price : $8.95]
FDA clears a Damae Medical 510(k) for its deepLive, an artificial intelligence-based imaging tool that provides real-time, three-d...[ Price : $8.95]
CDER's Office of Prescription Drug Promotion sends an untitled letter to Edenbridge Pharmaceuticals over Hemady promotional materi...[ Price : $8.95]
FDA accepts for review a Corcept Therapeutics NDA for relacorilant and its use in treating patients with endogenous hypercortisoli...[ Price : $8.95]
Protagonist Therapeutics and Takeda report positive topline results for the Phase 3 VERIFY study that is evaluating rusfertide for...[ Price : $8.95]
Lexicon Pharmaceuticals says it will advance pain drug pilavapadin 10mg into a planned Phase 3 trial based on just-announced Phase...[ Price : $8.95]
PharmaTher also said it was working with its third-party manufacturing partner to resolve the deficiencies.